Vonoprazan Fumarate
2 NDCs across 1 manufacturer|0 Generic,2 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 1, 2023. In 2024, Medicare Part D spent $31 million on Vonoprazan Fumarate across 38,000 claims for 15,000 beneficiaries.
Vonoprazan Fumarate is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $22.41 to $22.42 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$22.41 – $22.42
per EA
7d Activity
avg -0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing VONOPRAZAN FUMARATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VOQUEZNA 20 MG TABLET | $22.4232 per EA | -0.03% |
VOQUEZNA 10 MG TABLET | $22.4050 per EA | 0.00% |
Frequently Asked Questions
How much does Medicare spend on Vonoprazan Fumarate?
In 2024, Medicare Part D spent $31 million on Vonoprazan Fumarate across 38,000 claims for 15,000 beneficiaries.
How many Vonoprazan Fumarate products are on the market?
The Vonoprazan Fumarate drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Vonoprazan Fumarate?
NADAC reference prices for Vonoprazan Fumarate range from $22.4050 to $22.4232 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Vonoprazan Fumarate?
1 manufacturer lists Vonoprazan Fumarate in NADAC. Ranked by number of NDCs, the largest are Phathom Pharmaceuticals Inc. (2).
How has the price of Vonoprazan Fumarate changed recently?
Over the past 7 days, 0 Vonoprazan Fumarate NDCs rose and 1 fell, with a market-wide average change of -0.0%.